Although there are a multitude of CBD products available on the market, CBD oil tends to be the most popular product among users. CBD oil is beloved for its easy-to-use formula and high bioavailability. Touted for its many effects on the body and mind, people use CBD oil for a variety of reasons — most often to increase general health and wellbeing.
THC, an intoxicating and illegal substance, is responsible for causing marijuana users to get “high.” Unlike THC, CBD is non-psychoactive because it does not act on the same pathways as THC. Thus, it is impossible to get “high” by smoking or ingesting CBD or CBD oil extracted from industrial hemp plants, as they only have minuscule traces of THC (<0.3%).
According to a growing body of research, CBD may play a role in the growth of new brain cells, a process known as neurogenesis. CBD is also widely recognized as having anti-oxidant and anti-inflammatory abilities, which make CBD a promising therapy for a wide range of conditions, from neurological disorders to autoimmune diseases to chronic pain and depression.
Last year, the National Academies of Sciences, Engineering and Medicine released a nearly 500-page report on the health effects of cannabis and cannabinoids. A committee of 16 experts from a variety of scientific and medical fields analyzed the available evidence — more than 10,000 scientific abstracts in all. Because so few studies examine the effects of CBD on its own, the panel did not issue any findings about CBD specifically, but it did reach some conclusions about cannabis and cannabinoids more generally. The researchers determined that there is “conclusive or substantial evidence” supporting the use of cannabis or cannabinoids for chronic pain in adults, multiple sclerosis-related spasticity (a kind of stiffness and muscle spasms), and chemotherapy-induced nausea and vomiting. The committee also found “moderate” evidence that cannabis or cannabinoids can reduce sleep disturbances in people with obstructive sleep apnea, fibromyalgia, chronic pain and multiple sclerosis, as well as “limited” evidence that these substances can improve symptoms of Tourette’s syndrome, increase appetite and stem weight loss in people with HIV/AIDs, and improve symptoms of PTSD and anxiety.
The cannabis compound has become so popular that you can find it nearly anywhere, in nearly anything—including pills, creams, sprays, oils and even protein powder. There are CBD massages, CBD for your dog and even CBD lube. One popular new trend is adding CBD to drinks — coffee, tea and, yes, cocktails, with the idea that it will give you a little extra dose of happy.
Cannabidiol has been found to act as an antagonist of GPR55, a G protein-coupled receptor and putative cannabinoid receptor that is expressed in the caudate nucleus and putamen in the brain. It has also been found to act as an inverse agonist of GPR3, GPR6, and GPR12. Although currently classified as orphan receptors, these receptors are most closely related phylogenetically to the cannabinoid receptors. In addition to orphan receptors, CBD has been shown to act as a serotonin 5-HT1A receptor partial agonist, and this action may be involved in its antidepressant, anxiolytic, and neuroprotective effects. It is an allosteric modulator of the μ- and δ-opioid receptors as well. The pharmacological effects of CBD have additionally been attributed to PPARγ agonism and intracellular calcium release.
Willie’s Remedy, the “hemp derived cannabis products to supplement a legendary life well-lived” per their website, will debut in Colorado some time in September. From what little can be gleaned from the website, the whole bean coffee will be “small batch” roasted, “infused with full spectrum CBD oil derived from American sourced and organically grown hemp,” and sold in eight-ounce tins.
CBD IS AN ABBREVIATION FOR CANNABIDIOL, A CHEMICAL COMPOUND FOUND NATURALLY IN THE CANNABIS PLANT. IT IS NOT MIND ALTERING LIKE MARIJUANA, WHICH MEANS CBD WILL NOT MAKE YOU HIGH. OVER THE PAST 40 YEARS THERE HAVE BEEN NUMEROUS STUDIES THAT HIGHLIGHT THE POTENTIAL OF CBD. RESEARCHERS DISCOVERED THE HUMAN ENDOCANNABINOID SYSTEM (ECS), WHICH IS THE SYSTEM THAT CBD INTERACTS WITH.
Though unflavored and priced higher than competitors, Green Roads CBD oils are made by a trusted manufacturer and use organically grown hemp. Following the CO2 supercritical fluid extraction process, board-certified pharmacists formulate the tincture by hand. Green Roads only sells CBD isolates, so if you’re looking for broad-spectrum products look to some of our other recommendations.
Research on low levels of CBD is, you guessed it, incredibly limited; just a single paper on the medical research database PubMed specifically looked at CBD in these low doses, as a treatment for Crohn’s disease. (It was not found to have an effect.) As such, it wouldn’t be fair to say that 5 or even 20 mg of CBD oil in your coffee is proven to do nothing; that hasn’t been proven. It’s more accurate to say that 20 mg of CBD oil in your coffee has never been proven to do much of anything, and related research indicates that’s probably way too low of a dose to have any measurable effect.
If you hate shopping as much as I do, you’ll love a boutique that helps you get through it with a little CBD and caffeine mix. Seldom Seen sells bottled CBD cold brew courtesy of a brand called Mary Joe from Costa Mesa. The shop is in Hayes Valley, so expect Hayes Valley prices, but if your style is monochromatic and relaxed, you’ll probably love their curated collection of clothes, shoes and accessories for both men and women.
In the United States, over three million people suffer from epilepsy – 470,000 of those people are children. Epilepsy is a disorder of the brain that causes seizures – of which there are over thirty different kinds, ranging from mild and infrequent to life-threatening. Not surprisingly, people with epilepsy face significant challenges – from the cost of healthcare to work limitations and social isolation.
^ Jump up to: a b c d Campos AC, Moreira FA, Gomes FV, Del Bel EA, Guimarães FS (December 2012). "Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders". Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences (Review). 367 (1607): 3364–78. doi:10.1098/rstb.2011.0389. PMC 3481531. PMID 23108553.